These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 5190600)

  • 21. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G; Tallarida G; Baldoni F; Raimondi G; Grimaldi I; Sangiorgi M
    Clin Ter; 1985 Jul; 114(1):3-26. PubMed ID: 2864161
    [No Abstract]   [Full Text] [Related]  

  • 24. [New information on obliterative disease of the peripheral vessels and its treatment].
    Masek O
    Vnitr Lek; 1968 Mar; 14(3):301-3. PubMed ID: 5638968
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of peripheral ischemizing arteriopathies with diisopropylammonium dichloroethanoate (Diedì), a drug with action prevalent on respiratory tissue metabolism].
    Maggi GC; Tartara A
    Minerva Cardioangiol; 1965 Jul; 13(7):382-3. PubMed ID: 5838538
    [No Abstract]   [Full Text] [Related]  

  • 27. [OBLITERATING ARTERIOPATHIES OF THE EXTREMITIES].
    ENJALBERT A; GEDEON A
    Toulouse Med; 1964 Feb; 65():191-205. PubMed ID: 14143539
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antiischemic efficacy of trimetazidine in patients with intermittent claudication and effort angina].
    Syrkin AL; Artiukhina EG; Kanorskiĭ SG; Chuntyzheva MM
    Kardiologiia; 2003; 43(7):49-52. PubMed ID: 12891299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic image (195). A man with blue finger tips].
    de Vries PA; van Tol KM
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1290. PubMed ID: 15279212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlled trial of propranolol in intermittent claudication.
    Reichert N; Shibolet S; Adar R; Gafni J
    Clin Pharmacol Ther; 1975 May; 17(5):612-5. PubMed ID: 1092515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T
    Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mydocalm administered in electrophoresis].
    Chmielewski F
    Pol Tyg Lek; 1971 Jul; 26(30):1170-2. PubMed ID: 5092988
    [No Abstract]   [Full Text] [Related]  

  • 35. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [THERAPEUTIC USES OF ORAL HYPOGLYCEMIC DRUGS IN SOME PERIPHERAL ARTERIOPATHIES].
    LOMBARDI V; CANGI G; MATTII R
    Clin Ter; 1963 Aug; 26():311-30. PubMed ID: 14055216
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thromboangiitis obliterans (Buerger disease) discovered by symptoms of arthralgia in a young woman].
    Kovacsovics-Bankowski M; Gerster JC
    Praxis (Bern 1994); 1997 Dec; 86(49):1945-8. PubMed ID: 9480517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 40. [Physiopathology and therapy of obliterating arteriopathies].
    Schettler G; Mörl H
    Clin Ter; 1979 Jan; 88(1):3-19. PubMed ID: 436376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.